Integra LifeSciences Holdings Corporation
311 Enterprise Drive
Plainsboro
New Jersey
08536
United States
Tel: 609-275-0500
Fax: 609-275-3684
Website: http://www.integra-ls.com/
372 articles about Integra LifeSciences Holdings Corporation
-
Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024
4/18/2024
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that it has rescheduled the release of the Company’s first quarter 2024 financial results to Monday, May 6, 2024.
-
Integra LifeSciences Completes the Acquisition of Acclarent, Inc.
4/1/2024
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed its acquisition of Acclarent, Inc., a pioneer in ear, nose and throat (ENT) surgical interventions.
-
Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
2/28/2024
Integra LifeSciences Holdings Corporation reported financial results for the fourth quarter and full year ended December 31, 2023.
-
Integra LifeSciences Announces Leadership Transition Plan
2/28/2024
Integra LifeSciences Holdings Corporation, a leading global medical technology company, announced that Jan De Witte has informed the Board of Directors of his intention to retire from his position as president and chief executive officer of Integra following the appointment of a successor, which the Company expects to occur by the end of 2024.
-
Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024
2/7/2024
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2023 financial results on Wednesday, February 28, 2024, prior to the market open.
-
Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
1/5/2024
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president and chief executive officer will present at the 42nd Annual J.P. Morgan Healthcare conference on January 10, 2024 at 1:30pm ET.
-
Integra LifeSciences Announces Definitive Agreement to Acquire Acclarent®
12/13/2023
Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today announced that it has entered into a definitive agreement to acquire Acclarent, Inc. from Ethicon, Inc., a Johnson & Johnson MedTech company for $275 million in cash at closing, subject to customary purchase price adjustments, and an additional $5 million upon the achievement of certain regulatory milestones.
-
Integra LifeSciences Appoints Jeff Graves, Ph.D., to Board of Directors
12/12/2023
Integra LifeSciences Holdings Corporation, a leading global medical technology company, announced that Jeff Graves, Ph.D., president and chief executive officer of 3D Systems Corporation, was appointed to the company’s board of directors, effective immediately.
-
Integra LifeSciences Reports Third Quarter 2023 Financial Results
10/25/2023
Integra LifeSciences Holdings Corporation, a leading global medical technology company, reported financial results for the third quarter ending September 30, 2023.
-
Integra LifeSciences to Host Third Quarter 2023 Financial Results Conference Call on October 25, 2023
10/4/2023
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2023 financial results on Wednesday, October 25, 2023, prior to the market open.
-
Integra LifeSciences to Present at the 2023 Wells Fargo Healthcare Conference
9/1/2023
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the 2023 Wells Fargo Healthcare Conference on September 6, 2023 at 1:30 p.m. EST.
-
Integra LifeSciences Reports Second Quarter 2023 Financial Results
7/26/2023
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2023.
-
Integra LifeSciences to Host Second Quarter 2023 Financial Results Conference Call on July 27, 2023
7/3/2023
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2023 financial results on Thursday, July 27, 2023, prior to the market open.
-
Integra LifeSciences Announces Complete Enrollment in DuraSorb® Monofilament Mesh U.S. IDE Study
6/28/2023
Integra LifeSciences Holding Corporation, a leading global medical technology company, announced the completion of patient enrollment in the DuraSorb U.S. investigational device exemption clinical study for two-stage breast reconstruction.
-
Integra LifeSciences Appoints Lea Daniels Knight, Executive Vice President and Chief Financial Officer
6/21/2023
Integra LifeSciences Holdings Corporation announced the appointment of Lea Daniels Knight as executive vice president and chief financial officer, effective June 28, 2023.
-
Integra LifeSciences Opens New Center of Innovation and Learning
5/11/2023
Integra LifeSciences Holdings Corporation, a leading global medical technology company, hosted a ribbon-cutting ceremony on Thursday, May 11, 2023, to commemorate the grand opening and dedication of its new center of innovation and learning to Dr. Richard E. Caruso, late founder of the company, in Plainsboro, New Jersey.
-
Integra LifeSciences To Host Investor Day On May 4, 2023
5/3/2023
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will host an Investor Day meeting from 8:30 a.m. to approximately 12:00 p.m., U.S. eastern time on May 4, 2023 in New York, NY.
-
Integra LifeSciences Reports First Quarter 2023 Financial Results
4/26/2023
Integra LifeSciences Holdings Corporation, a leading global medical technology company, reported financial results for the first quarter ending March 31, 2023.
-
Integra LifeSciences to Host First Quarter 2023 Financial Results Conference Call on April 26, 2023
4/3/2023
Integra LifeSciences Holdings Corporation, a leading global medical technology company, will release first quarter 2023 financial results on Wednesday, April 26, 2023, prior to the market open.
-
Integra LifeSciences Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides 2023 Financial Guidance
2/22/2023
Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2022, consistent with its preliminary financial results announced on January 10, 2023 and January 25, 2023.